Cargando…

Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study

Detalles Bibliográficos
Autores principales: Li, Yuan, Wang, Lin, Zhang, Jianning, Han, Hui, Liu, Han, Li, Chaoyang, Guo, Haipeng, Chen, Yuguo, Chen, Xiaomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589771/
https://www.ncbi.nlm.nih.gov/pubmed/34782857
http://dx.doi.org/10.3389/fcvm.2021.784904
_version_ 1784598803219742720
author Li, Yuan
Wang, Lin
Zhang, Jianning
Han, Hui
Liu, Han
Li, Chaoyang
Guo, Haipeng
Chen, Yuguo
Chen, Xiaomei
author_facet Li, Yuan
Wang, Lin
Zhang, Jianning
Han, Hui
Liu, Han
Li, Chaoyang
Guo, Haipeng
Chen, Yuguo
Chen, Xiaomei
author_sort Li, Yuan
collection PubMed
description
format Online
Article
Text
id pubmed-8589771
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85897712021-11-14 Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study Li, Yuan Wang, Lin Zhang, Jianning Han, Hui Liu, Han Li, Chaoyang Guo, Haipeng Chen, Yuguo Chen, Xiaomei Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2021-10-29 /pmc/articles/PMC8589771/ /pubmed/34782857 http://dx.doi.org/10.3389/fcvm.2021.784904 Text en Copyright © 2021 Li, Wang, Zhang, Han, Liu, Li, Guo, Chen and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Li, Yuan
Wang, Lin
Zhang, Jianning
Han, Hui
Liu, Han
Li, Chaoyang
Guo, Haipeng
Chen, Yuguo
Chen, Xiaomei
Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study
title Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study
title_full Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study
title_fullStr Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study
title_full_unstemmed Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study
title_short Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study
title_sort corrigendum: oseltamivir improved thrombocytopenia during veno-arterial extracorporeal membrane oxygenation in adults with refractory cardiac failure: a single-center retrospective real-world study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589771/
https://www.ncbi.nlm.nih.gov/pubmed/34782857
http://dx.doi.org/10.3389/fcvm.2021.784904
work_keys_str_mv AT liyuan corrigendumoseltamivirimprovedthrombocytopeniaduringvenoarterialextracorporealmembraneoxygenationinadultswithrefractorycardiacfailureasinglecenterretrospectiverealworldstudy
AT wanglin corrigendumoseltamivirimprovedthrombocytopeniaduringvenoarterialextracorporealmembraneoxygenationinadultswithrefractorycardiacfailureasinglecenterretrospectiverealworldstudy
AT zhangjianning corrigendumoseltamivirimprovedthrombocytopeniaduringvenoarterialextracorporealmembraneoxygenationinadultswithrefractorycardiacfailureasinglecenterretrospectiverealworldstudy
AT hanhui corrigendumoseltamivirimprovedthrombocytopeniaduringvenoarterialextracorporealmembraneoxygenationinadultswithrefractorycardiacfailureasinglecenterretrospectiverealworldstudy
AT liuhan corrigendumoseltamivirimprovedthrombocytopeniaduringvenoarterialextracorporealmembraneoxygenationinadultswithrefractorycardiacfailureasinglecenterretrospectiverealworldstudy
AT lichaoyang corrigendumoseltamivirimprovedthrombocytopeniaduringvenoarterialextracorporealmembraneoxygenationinadultswithrefractorycardiacfailureasinglecenterretrospectiverealworldstudy
AT guohaipeng corrigendumoseltamivirimprovedthrombocytopeniaduringvenoarterialextracorporealmembraneoxygenationinadultswithrefractorycardiacfailureasinglecenterretrospectiverealworldstudy
AT chenyuguo corrigendumoseltamivirimprovedthrombocytopeniaduringvenoarterialextracorporealmembraneoxygenationinadultswithrefractorycardiacfailureasinglecenterretrospectiverealworldstudy
AT chenxiaomei corrigendumoseltamivirimprovedthrombocytopeniaduringvenoarterialextracorporealmembraneoxygenationinadultswithrefractorycardiacfailureasinglecenterretrospectiverealworldstudy